↓ Skip to main content

Dove Medical Press

Erlotinib in the treatment of advanced pancreatic cancer

Overview of attention for article published in Biologics: Targets & Therapy, March 2008
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Among the highest-scoring outputs from this source (#24 of 286)
  • High Attention Score compared to outputs of the same age (91st percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

news
1 news outlet
patent
9 patents

Citations

dimensions_citation
64 Dimensions

Readers on

mendeley
76 Mendeley
Title
Erlotinib in the treatment of advanced pancreatic cancer
Published in
Biologics: Targets & Therapy, March 2008
DOI 10.2147/btt.s1832
Pubmed ID
Authors

Robin K Kelley, Andrew H Ko

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 76 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 76 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 14 18%
Researcher 12 16%
Student > Bachelor 8 11%
Other 7 9%
Student > Master 7 9%
Other 14 18%
Unknown 14 18%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 18 24%
Medicine and Dentistry 16 21%
Agricultural and Biological Sciences 14 18%
Chemistry 5 7%
Arts and Humanities 2 3%
Other 4 5%
Unknown 17 22%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 13. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 December 2020.
All research outputs
#2,711,589
of 25,837,817 outputs
Outputs from Biologics: Targets & Therapy
#24
of 286 outputs
Outputs of similar age
#7,709
of 97,793 outputs
Outputs of similar age from Biologics: Targets & Therapy
#2
of 10 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 286 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.3. This one has done particularly well, scoring higher than 91% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 97,793 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 91% of its contemporaries.
We're also able to compare this research output to 10 others from the same source and published within six weeks on either side of this one. This one has scored higher than 8 of them.